Our Blog

Dr. Jastrab speaks on a panel at Advanced Therapies Week in February 2026. By Abigail Jastrab, PharmD, BCPS Director, Patient Engagement and Clinical Innovation As...

In this Drug Channels Institute guest post, “Targeted Reach, Tighter Relationships: Why Rare Disease Launches Are Different,” PANTHERx’s Chief Commercial & Clinical Officer, Dr. Richard...

Dr. Richard Faris, our Chief Commercial and Clinical Officer, recently submitted a proposal on behalf of PANTHERx in response to the FDA’s request for public...

PANTHERx associates celebrate Collierville’s first dispense in August 2025. PANTHERx Rare Pharmacy is proud to announce the opening of our new state-of-the-art pharmacy fulfillment center...

Dr. Richard Faris, PhD, MSc, RPh, will bring his extensive expertise to NASP, helping to guide the organization as it advances specialty pharmacy, promotes innovation,...

Bansi explores how the emerging model of “Rare Pharmacy” addresses the challenges rare diseases pose to patients, caregivers, and the healthcare system. His perspective highlights...

Dr. Richard Faris outlines the key factors for commercialization success when a manufacturer launches treatments for rare and orphan diseases. He explains the key considerations...

As a five-time MMIT Patient Choice Award Winner with a portfolio of 25+ rare programs, PANTHERx attributes much of our success to our ability to...

PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity....

Change has been a constant in the specialty pharmacy industry since its inception over two decades ago. New medications are routinely launched, more patient populations...